Clinical Trials Logo

Clinical Trial Summary

before major hepatectomy, in case of insufisant future liver remanent volume or function, portal embolization is a routinely used method to enable growth of the future liver remnant. Recently liver venous deprivation has been described in some pioneer centre. The results are processing with greater and faster hypertrophy allowing probably less drop out from the embolization to surgery compared to portal embolization.

In major hepatectomy, and specially in right or extended right hepatectomy the segment IV plays an important role in the proportion of future liver remnant.

Despite the growing interest in the scientific community for liver venous deprivation many aspects concerning the liver hypertrophy remains unexplored. In particular the the degree of hypertrophy of segment IV after liver venous deprivation compared to portal embolization.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04370132
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date January 1, 2015
Completion date April 15, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03762876 - Evaluation of Trans-Hepatic Flow Changes in Major Hepatectomy
Recruiting NCT02390713 - Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy Phase 1/Phase 2